世界の臨床における質量分析器市場2020:企業別、地域別、種類別、用途別、市場予測2025

GlobalInfoResearchが発行した調査報告書(GIR20OC05966)
◆英語タイトル:Global Mass Spectrometry in Clinical Market 2020 by Company, Regions, Type and Application, Forecast to 2025
◆商品コード:GIR20OC05966
◆発行会社(リサーチ会社):GlobalInfoResearch
◆発行日:2020年10月(※2024年版があります。お問い合わせください。)
◆ページ数:102
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,480 ⇒換算¥515,040見積依頼/購入/質問フォーム
Multi User(10名様閲覧用)USD5,220 ⇒換算¥772,560見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalInfoResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。

本書では、臨床における質量分析器の世界市場を調査対象にし、臨床における質量分析器の市場概要、企業情報、企業別売上・市場シェア、地域別市場分析(北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ)、種類別分析(単一質量分析、混合質量分析)、用途別分析(病院、クリニック、その他)、市場予測(2021年~2025年)情報などを整理しました。
・市場概要
・企業情報:SCIEX、Beckman Coulter、PerkinElmer、Agilent Technologies、Agena Bioscience、Thermo Fisher Scientific、Hiden Analytical、Shimadzu、Waters
・企業別売上、市場シェア
・臨床における質量分析器の地域別市場分析
・臨床における質量分析器の北米市場規模2015-2020:アメリカ、カナダ、メキシコ
・臨床における質量分析器のヨーロッパ市場規模2015-2020:ドイツ、イギリス、フランス、ロシアなど
・臨床における質量分析器のアジア市場規模2015-2020:日本、中国、韓国、インド、東南アジアなど
・臨床における質量分析器の南米市場規模2015-2020:ブラジル、アルゼンチンなど
・臨床における質量分析器の中東・アフリカ市場規模2015-2020:サウジアラビア、トルコ、エジプト、南アフリカなど
・臨床における質量分析器の種類別市場規模2015-2020:単一質量分析、混合質量分析
・臨床における質量分析器の用途別市場規模2015-2020:病院、クリニック、その他
・臨床における質量分析器の世界市場予測2021-2025:地域別、種類別、用途別
・調査の結果・結論
【レポートの概要】

Market Overview
The global Mass Spectrometry in Clinical market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

The Mass Spectrometry in Clinical market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
Mass Spectrometry in Clinical market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Mass Spectrometry in Clinical market has been segmented into:
Single Mass Spectrometry
Mixed Mass Spectrometry

By Application, Mass Spectrometry in Clinical has been segmented into:
Hospitals
Clinics
Others

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Mass Spectrometry in Clinical market presented in the report. This section sheds light on the sales growth of different regional and country-level Mass Spectrometry in Clinical markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Mass Spectrometry in Clinical market.

The report offers in-depth assessment of the growth and other aspects of the Mass Spectrometry in Clinical market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Competitive Landscape and Mass Spectrometry in Clinical Market Share Analysis
Mass Spectrometry in Clinical competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Mass Spectrometry in Clinical sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Mass Spectrometry in Clinical sales, revenue and market share for each player covered in this report.

The major players covered in Mass Spectrometry in Clinical are:
SCIEX
Beckman Coulter
PerkinElmer
Agilent Technologies
Agena Bioscience
Thermo Fisher Scientific
Hiden Analytical
Shimadzu
Waters

【レポートの目次】

1 Mass Spectrometry in Clinical Market Overview
1.1 Product Overview and Scope of Mass Spectrometry in Clinical
1.2 Classification of Mass Spectrometry in Clinical by Type
1.2.1 Global Mass Spectrometry in Clinical Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Mass Spectrometry in Clinical Revenue Market Share by Type in 2019
1.2.3 Single Mass Spectrometry
1.2.4 Mixed Mass Spectrometry
1.3 Global Mass Spectrometry in Clinical Market by Application
1.3.1 Overview: Global Mass Spectrometry in Clinical Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Global Mass Spectrometry in Clinical Market by Regions
1.4.1 Global Mass Spectrometry in Clinical Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Mass Spectrometry in Clinical (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Mass Spectrometry in Clinical Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Mass Spectrometry in Clinical Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Mass Spectrometry in Clinical Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Mass Spectrometry in Clinical Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Mass Spectrometry in Clinical Status and Prospect (2015-2025)
2 Company Profiles
2.1 SCIEX
2.1.1 SCIEX Details
2.1.2 SCIEX Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 SCIEX SWOT Analysis
2.1.4 SCIEX Product and Services
2.1.5 SCIEX Mass Spectrometry in Clinical Revenue, Gross Margin and Market Share (2018-2019)
2.2 Beckman Coulter
2.2.1 Beckman Coulter Details
2.2.2 Beckman Coulter Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Beckman Coulter SWOT Analysis
2.2.4 Beckman Coulter Product and Services
2.2.5 Beckman Coulter Mass Spectrometry in Clinical Revenue, Gross Margin and Market Share (2018-2019)
2.3 PerkinElmer
2.3.1 PerkinElmer Details
2.3.2 PerkinElmer Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 PerkinElmer SWOT Analysis
2.3.4 PerkinElmer Product and Services
2.3.5 PerkinElmer Mass Spectrometry in Clinical Revenue, Gross Margin and Market Share (2018-2019)
2.4 Agilent Technologies
2.4.1 Agilent Technologies Details
2.4.2 Agilent Technologies Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Agilent Technologies SWOT Analysis
2.4.4 Agilent Technologies Product and Services
2.4.5 Agilent Technologies Mass Spectrometry in Clinical Revenue, Gross Margin and Market Share (2018-2019)
2.5 Agena Bioscience
2.5.1 Agena Bioscience Details
2.5.2 Agena Bioscience Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Agena Bioscience SWOT Analysis
2.5.4 Agena Bioscience Product and Services
2.5.5 Agena Bioscience Mass Spectrometry in Clinical Revenue, Gross Margin and Market Share (2018-2019)
2.6 Thermo Fisher Scientific
2.6.1 Thermo Fisher Scientific Details
2.6.2 Thermo Fisher Scientific Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Thermo Fisher Scientific SWOT Analysis
2.6.4 Thermo Fisher Scientific Product and Services
2.6.5 Thermo Fisher Scientific Mass Spectrometry in Clinical Revenue, Gross Margin and Market Share (2018-2019)
2.7 Hiden Analytical
2.7.1 Hiden Analytical Details
2.7.2 Hiden Analytical Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Hiden Analytical SWOT Analysis
2.7.4 Hiden Analytical Product and Services
2.7.5 Hiden Analytical Mass Spectrometry in Clinical Revenue, Gross Margin and Market Share (2018-2019)
2.8 Shimadzu
2.8.1 Shimadzu Details
2.8.2 Shimadzu Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Shimadzu SWOT Analysis
2.8.4 Shimadzu Product and Services
2.8.5 Shimadzu Mass Spectrometry in Clinical Revenue, Gross Margin and Market Share (2018-2019)
2.9 Waters
2.9.1 Waters Details
2.9.2 Waters Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Waters SWOT Analysis
2.9.4 Waters Product and Services
2.9.5 Waters Mass Spectrometry in Clinical Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Mass Spectrometry in Clinical Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Mass Spectrometry in Clinical Players Market Share
3.2.2 Top 10 Mass Spectrometry in Clinical Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Mass Spectrometry in Clinical Revenue and Market Share by Regions
4.2 North America Mass Spectrometry in Clinical Revenue and Growth Rate (2015-2020)
4.3 Europe Mass Spectrometry in Clinical Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Mass Spectrometry in Clinical Revenue and Growth Rate (2015-2020)
4.5 South America Mass Spectrometry in Clinical Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Mass Spectrometry in Clinical Revenue and Growth Rate (2015-2020)
5 North America Mass Spectrometry in Clinical Revenue by Countries
5.1 North America Mass Spectrometry in Clinical Revenue by Countries (2015-2020)
5.2 USA Mass Spectrometry in Clinical Revenue and Growth Rate (2015-2020)
5.3 Canada Mass Spectrometry in Clinical Revenue and Growth Rate (2015-2020)
5.4 Mexico Mass Spectrometry in Clinical Revenue and Growth Rate (2015-2020)
6 Europe Mass Spectrometry in Clinical Revenue by Countries
6.1 Europe Mass Spectrometry in Clinical Revenue by Countries (2015-2020)
6.2 Germany Mass Spectrometry in Clinical Revenue and Growth Rate (2015-2020)
6.3 UK Mass Spectrometry in Clinical Revenue and Growth Rate (2015-2020)
6.4 France Mass Spectrometry in Clinical Revenue and Growth Rate (2015-2020)
6.5 Russia Mass Spectrometry in Clinical Revenue and Growth Rate (2015-2020)
6.6 Italy Mass Spectrometry in Clinical Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Mass Spectrometry in Clinical Revenue by Countries
7.1 Asia-Pacific Mass Spectrometry in Clinical Revenue by Countries (2015-2020)
7.2 China Mass Spectrometry in Clinical Revenue and Growth Rate (2015-2020)
7.3 Japan Mass Spectrometry in Clinical Revenue and Growth Rate (2015-2020)
7.4 Korea Mass Spectrometry in Clinical Revenue and Growth Rate (2015-2020)
7.5 India Mass Spectrometry in Clinical Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Mass Spectrometry in Clinical Revenue and Growth Rate (2015-2020)
8 South America Mass Spectrometry in Clinical Revenue by Countries
8.1 South America Mass Spectrometry in Clinical Revenue by Countries (2015-2020)
8.2 Brazil Mass Spectrometry in Clinical Revenue and Growth Rate (2015-2020)
8.3 Argentina Mass Spectrometry in Clinical Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Mass Spectrometry in Clinical by Countries
9.1 Middle East & Africa Mass Spectrometry in Clinical Revenue by Countries (2015-2020)
9.2 Saudi Arabia Mass Spectrometry in Clinical Revenue and Growth Rate (2015-2020)
9.3 UAE Mass Spectrometry in Clinical Revenue and Growth Rate (2015-2020)
9.4 Egypt Mass Spectrometry in Clinical Revenue and Growth Rate (2015-2020)
9.5 South Africa Mass Spectrometry in Clinical Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Mass Spectrometry in Clinical Revenue and Market Share by Type (2015-2020)
10.2 Global Mass Spectrometry in Clinical Market Forecast by Type (2019-2024)
10.3 Single Mass Spectrometry Revenue Growth Rate (2015-2025)
10.4 Mixed Mass Spectrometry Revenue Growth Rate (2015-2025)
11 Global Mass Spectrometry in Clinical Market Segment by Application
11.1 Global Mass Spectrometry in Clinical Revenue Market Share by Application (2015-2020)
11.2 Mass Spectrometry in Clinical Market Forecast by Application (2019-2024)
11.3 Hospitals Revenue Growth (2015-2020)
11.4 Clinics Revenue Growth (2015-2020)
11.5 Others Revenue Growth (2015-2020)
12 Global Mass Spectrometry in Clinical Market Size Forecast (2021-2025)
12.1 Global Mass Spectrometry in Clinical Market Size Forecast (2021-2025)
12.2 Global Mass Spectrometry in Clinical Market Forecast by Regions (2021-2025)
12.3 North America Mass Spectrometry in Clinical Revenue Market Forecast (2021-2025)
12.4 Europe Mass Spectrometry in Clinical Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Mass Spectrometry in Clinical Revenue Market Forecast (2021-2025)
12.6 South America Mass Spectrometry in Clinical Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Mass Spectrometry in Clinical Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US

...

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の臨床における質量分析器市場2020:企業別、地域別、種類別、用途別、市場予測2025(Global Mass Spectrometry in Clinical Market 2020 by Company, Regions, Type and Application, Forecast to 2025)]についてメールでお問い合わせはこちらでお願いします。